Labat Africa Ltd - Asset Resilience Ratio
Labat Africa Ltd (LAB) has an Asset Resilience Ratio of 0.02% as of May 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Labat Africa Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Labat Africa Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Labat Africa Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Labat Africa Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ZAC0.00 | 0% |
| Short-term Investments | ZAC26.00K | 0.02% |
| Total Liquid Assets | ZAC26.00K | 0.02% |
Asset Resilience Insights
- Limited Liquidity: Labat Africa Ltd maintains only 0.02% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Labat Africa Ltd Industry Peers by Asset Resilience Ratio
Compare Labat Africa Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Alkem Laboratories Limited
NSE:ALKEM |
Drug Manufacturers - Specialty & Generic | 31.91% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Alkermes plc
F:8AK |
Drug Manufacturers - Specialty & Generic | 3.76% |
|
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623 |
Drug Manufacturers - Specialty & Generic | 4.97% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131 |
Drug Manufacturers - Specialty & Generic | 1.37% |
|
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436 |
Drug Manufacturers - Specialty & Generic | -2.56% |
Annual Asset Resilience Ratio for Labat Africa Ltd (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Labat Africa Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-08-31 | 0.02% | ZAC26.00K ≈ $13.82 |
ZAC123.39 Million ≈ $65.58K |
+0.00pp |
| 2023-08-31 | 0.02% | ZAC26.00K ≈ $13.82 |
ZAC132.94 Million ≈ $70.65K |
+0.01pp |
| 2022-08-31 | 0.01% | ZAC26.00K ≈ $13.82 |
ZAC207.62 Million ≈ $110.34K |
+0.00pp |
| 2021-08-31 | 0.01% | ZAC26.00K ≈ $13.82 |
ZAC222.56 Million ≈ $118.28K |
-0.60pp |
| 2019-08-31 | 0.62% | ZAC1.21 Million ≈ $643.58 |
ZAC196.53 Million ≈ $104.45K |
+0.45pp |
| 2018-08-31 | 0.16% | ZAC103.00K ≈ $54.74 |
ZAC62.90 Million ≈ $33.43K |
+0.14pp |
| 2017-08-31 | 0.02% | ZAC9.92K ≈ $5.27 |
ZAC45.85 Million ≈ $24.37K |
-0.02pp |
| 2016-08-31 | 0.04% | ZAC9.92K ≈ $5.27 |
ZAC23.53 Million ≈ $12.51K |
0.00pp |
| 2015-08-31 | 0.05% | ZAC10.00K ≈ $5.31 |
ZAC21.64 Million ≈ $11.50K |
+0.00pp |
| 2014-08-31 | 0.05% | ZAC9.92K ≈ $5.27 |
ZAC21.99 Million ≈ $11.68K |
+0.01pp |
| 2013-08-31 | 0.04% | ZAC9.92K ≈ $5.27 |
ZAC26.58 Million ≈ $14.12K |
+0.02pp |
| 2011-08-31 | 0.02% | ZAC10.00K ≈ $5.31 |
ZAC50.85 Million ≈ $27.03K |
-0.36pp |
| 2010-08-31 | 0.38% | ZAC179.00K ≈ $95.13 |
ZAC47.59 Million ≈ $25.29K |
+0.06pp |
| 2009-08-31 | 0.31% | ZAC179.00K ≈ $95.13 |
ZAC57.36 Million ≈ $30.48K |
+0.15pp |
| 2006-08-31 | 0.17% | ZAC350.00K ≈ $186.01 |
ZAC210.52 Million ≈ $111.88K |
-5.41pp |
| 2005-08-31 | 5.58% | ZAC9.70 Million ≈ $5.15K |
ZAC173.79 Million ≈ $92.36K |
-10.61pp |
| 2004-08-31 | 16.19% | ZAC37.02 Million ≈ $19.67K |
ZAC228.66 Million ≈ $121.52K |
-4.24pp |
| 2003-08-31 | 20.43% | ZAC55.39 Million ≈ $29.43K |
ZAC271.12 Million ≈ $144.09K |
+6.84pp |
| 2002-08-31 | 13.59% | ZAC37.95 Million ≈ $20.17K |
ZAC279.21 Million ≈ $148.38K |
-- |
About Labat Africa Ltd
Labat Africa Limited, an investment holding company, engages in the technology, logistics, and healthcare activities in South Africa. The company operates through Technology, Logistics, and Healthcare segments. It engages in the manufacture and distribution of integrated circuits, including micro electronic systems; transportation of coals and minerals for mines; and sale of medical cannabis, as … Read more